LiGluR is based on the kainate receptor GluK2 (formerly GluR6), which plays distinct roles at excitatory and inhibitory synapses throughout the brain and has been implicated in a variety of neurological diseases, including mood disorders and epilepsy (Contractor et al., 2011; Lerma and Marques, 2013). This evidence concerns the gene GRIK2 and mood disorder.